DualityBio and BioNTech Collaborate on Groundbreaking $1.5 Billion Cancer Therapy DealBy Saba KashApril 4, 20230 DualityBio and BioNTech Collaborate on Groundbreaking Cancer Therapy Deal. Find out what this means for the future of cancer treatment.
